What is Dataplus Pharma Services?
Dataplus Pharma Services, Inc. (DATAPLUS) operates as a clinical data services organization, specializing in comprehensive data analysis and support for the pharmaceutical, biotechnology, and medical device sectors. Their service portfolio encompasses critical areas such as clinical data management, data standards implementation, statistical analysis, biostatistics, clinical operations, and electronic submissions. DATAPLUS plays a vital role in supporting clinical trials across all phases, from early development to late-stage studies, spanning diverse therapeutic areas. Furthermore, the company actively develops software solutions designed to enhance the efficiency and effectiveness of clinical data services, positioning itself as an innovator in the field.
How much funding has Dataplus Pharma Services raised?
Dataplus Pharma Services has raised a total of $315K across 1 funding round:
Debt
$315K
Debt (2021): $315K with participation from PPP
Key Investors in Dataplus Pharma Services
PPP
Public-Private Partnership
What's next for Dataplus Pharma Services?
With a substantial late-stage funding context, Dataplus Pharma Services is poised for significant strategic advancements. The recent capital injection is expected to fuel expansion initiatives, potentially including the enhancement of existing service offerings, the development of new technological solutions, and the broadening of its market reach. This funding will likely enable DATAPLUS to solidify its competitive advantage by investing in advanced analytics capabilities and expanding its operational capacity to meet the growing demands of the life sciences industry. The company's focus on data integrity and efficiency in clinical trials positions it for continued success and leadership in its specialized market.
See full Dataplus Pharma Services company page
